Quantitative Gene Expression in Human Lung Epithelium
Quantitative Gene Expression in Human Lung Epithelium
批准号:
6764070
负责人:
SIMON D SPIVACK
金额:
$35.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30
关键词:
NAD(P)H dehydrogenasebiomarkerblood chemistrycancer riskcatalaseclinical researchcytochrome P450dietary constituentdrug related neoplasm /cancergender differencegene expressiongene mutationglutathione peroxidaseglutathione transferasehuman subjectlaser capture microdissectionliquid chromatography mass spectrometrylung neoplasmsmicroarray technologyp53 gene /proteinpolymerase chain reactionracial /ethnic differencerespiratory epitheliumsmokingstatistics /biometrysuperoxide dismutasetobacco abuse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Only one in ten current or ex-smokers contracts lung cancer over a lifetime. Lung cancer prevention and early detection strategies all require the identification of a high risk subgroup of tobacco-smokers upon which to focus intensive smoking cessation, chemoprevention and early disease screening efforts. Identifying this high risk subgroup is the long-term objective of this laboratory. Tobacco smoke's composition includes polyaromatic hydrocarbons, nitrosamines, and aromatic amines. Therefore, plausible candidate susceptibility genes may be hypothesized to include those genes encoding enzymes involved in initial carcinogen bioactivation and inactivation, and those involved in quenching in-situ-generated reactive oxygen species, in the lung epithelial cells of first contact with tobacco smoke. Expression of these genes in defined, smoke-exposed lung epithelium has been understudied as it relates to lung cancer risk. Our general hypothesis is that carcinogen and antioxidant metabolizing enzyme expression levels in lung epithelium, by quantitative assays, will identify smokers at high risk for lung cancer. With this laboratory's development of RNA-specific real-time quantitative expression assays for phase I and II carcinogen and oxidant metabolism enzymes, applied to laser microdissected human lung epithelium, it is now feasible to quantify cancer-relevant gene induction in the target cells of interest. Therefore, the specific aims are to 1) Quantify gene expression and interindividual expression differences of selected carcinogen-metabolizing enzymes and antioxidant enzymes in laser capture microdissected, in situ-exposed human lung epithelium, 2) Compare the observed differences with sensitive biomarkers of tobacco smoke exposure (plasma nicotine and cotinine) and an intermediate biomarker (p53- mutation frequency, spectrum, and methylation) and 3) Correlate the gene expression and p53 data with lung cancer case versus control status in multivariate models. We therefore will quantitatively define carcinogen and oxidant metabolizing gene expression - related susceptibility to lung cancer, for future adaptation to broad population screening strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative, age-related changes in genome and epigenome in human lung in relation to smoking
-
批准号:10320918
-
项目类别:
-
资助金额:$66.36万
-
财政年份:2019
-
负责人:SIMON D SPIVACK
-
依托单位:
Integrative, age-related changes in genome and epigenome in human lung in relation to smoking
-
批准号:9895468
-
项目类别:
-
资助金额:$65.23万
-
财政年份:2019
-
负责人:SIMON D SPIVACK
-
依托单位:
Assessing genome sequence integrity in normal human cells
-
批准号:10408704
-
项目类别:
-
资助金额:$66.61万
-
财政年份:2018
-
负责人:SIMON D SPIVACK
-
依托单位:
Assessing genome sequence integrity in normal human cells
-
批准号:10158475
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2018
-
负责人:SIMON D SPIVACK
-
依托单位:
Assessing genome sequence integrity in normal human cells
-
批准号:9759931
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2018
-
负责人:SIMON D SPIVACK
-
依托单位:
Clinical characteristics and outcomes of WTC-associated Sarcoidosis
-
批准号:9275649
-
项目类别:
-
资助金额:$49.23万
-
财政年份:2015
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled microRNAs leveraged for lung cancer risk assessment
-
批准号:8815714
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2014
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled microRNAs leveraged for lung cancer risk assessment
-
批准号:9122812
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2014
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:7796405
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:8109307
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:8506992
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:8284170
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker
-
批准号:9122683
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Early Functional Genetic and Epigenetic Changes in Human Lung Carcinogenesis
-
批准号:7817299
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2009
-
负责人:SIMON D SPIVACK
-
依托单位:
Early Functional Genetic and Epigenetic Changes in Human Lung Carcinogenesis
-
批准号:7941936
-
项目类别:
-
资助金额:$49.92万
-
财政年份:2009
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled Breath DNA Methylation in Lung Carcinogenesis
-
批准号:7666658
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2008
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled Breath DNA Methylation in Lung Carcinogenesis
-
批准号:7533238
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2008
-
负责人:SIMON D SPIVACK
-
依托单位:
Individual Promoter SNP and CpG Methylation Signatures
-
批准号:7031040
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2005
-
负责人:SIMON D SPIVACK
-
依托单位:
Individual Promoter SNP and CpG Methylation Signatures
-
批准号:6926610
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2005
-
负责人:SIMON D SPIVACK
-
依托单位:
Quantitative Gene Expression in Human Lung Epithelium
-
批准号:7228465
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2003
-
负责人:SIMON D SPIVACK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
-
批准号:81101308
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:李海霞
-
依托单位:
精神分裂症记忆障碍的脑网络组学研究
-
批准号:91132301
-
项目类别:重大研究计划
-
资助金额:350.0万元
-
批准年份:2011
-
负责人:蒋田仔
-
依托单位:
卵巢癌血浆microRNA潜在标志物筛选及调控机制研究
-
批准号:81072363
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:郑红
-
依托单位:
高原人群创伤性深静脉血栓血浆预测诊断蛋白标记物的发掘
-
批准号:81060151
-
项目类别:地区科学基金项目
-
资助金额:25.0万元
-
批准年份:2010
-
负责人:赵学凌
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: